Medplus Health Services Ltd Board Meeting

NSEBSE

₹666.9

(0.69%)

Oct 11, 2024|03:32:17 PM

Medplus Health CORPORATE ACTIONS

Action

From Date

14/10/2023

To Date

13/10/2024

Purpose	Board Meetings Date	Announcement Date
Board Meeting	2 Aug 2024	27 Jun 2024
Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 inter alia to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2024.under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 & Trading Window Closure under SEBI (Prohibition of Insider Trading)Regulations 2015 Outcome of Board Meeting held on August 2, 2024 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement dated on 02.08.2024)
Board Meeting	1 Jul 2024	1 Jul 2024
Outcome of Board Meeting pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015
Board Meeting	28 May 2024	30 Mar 2024
Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2024 Outcome of the Board Meeting held on May 28, 2024 under Regulation 30 of SEBI( Listing Obligations and Disclosure) Requirements) Regulations, 2015 Outcome of the Board Meeting held on May 28, 2024, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR) (As Per BSE Announcement Dated on 28.05.2024)
Board Meeting	21 Feb 2024	16 Feb 2024
Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/02/2024 inter alia to consider and approve to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30 2023. Outcome of Board meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of the Company (As Per BSE Announcement Dated on 21.02.2024)
Board Meeting	2 Feb 2024	27 Dec 2023
Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter ended December 31 2023. Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 and Companys Code of Conduct for Prevention of Insider Trading the trading window for the Designated Employees Directors and their relatives will remain closed from January 1 2024 to February 4 2024 i.e 48 hours of declaration of results to the Stock Exchanges. Outcome of Board meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR) of the Company Outcome of Board Meeting under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulations, 2015 of the Company (As Per BSE Announcement dated on 02.02.2024)
Board Meeting	8 Nov 2023	9 Oct 2023
Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2023 ,inter alia, to consider and approve Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve Un-audited financial results for the quarter and half year ended September 30, 2023 (As Per BSE Announcement dated on 25.10.2023) Outcome of Board meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of the Company (As Per BSE Announcement Dated on 08/11/2023) Intimation regarding newspaper publication of Extract of un-audited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2023 (As Per BSE Announcement dated on 09.11.2023)
Board Meeting	26 Oct 2023	26 Oct 2023
Outcome of Board meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR) of the Company.

Medplus Health: Related News

No Record Found

Invest wise with Expert advice

QUICKLINKS FOR Medplus Health Services Ltd

Derivatives

IPO

Mutual Funds

Nifty 50

Loans

Knowledge Center

News

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

Disclaimer

Research Disclaimer

Twitter Disclaimer

Advertisement Disclaimer

Terms & Conditions

RBI Policy Update

CSR Policy

Sitemap

ATTENTION INVESTORS

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
Pay 20% upfront margin of the transaction value to trade in cash market segment.
Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day.” – Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.